Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin F Bachmann

Showing results (241-250 of 250) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 250 results.
Allergy|March 8, 2023
The next generation virus-like particle platform for the treatment of peanut allergyJan M Sobczak, Pascal S Krenger, Federico Storni, et al.
Annals of Medicine|February 8, 2022
Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccinesQueenie Fernandes, Varghese Philipose Inchakalody, Maysaloun Merhi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2010
Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patientsDaniel E Speiser, Katrin Schwarz, Petra Baumgaertner, et al.
Allergy|November 28, 2019
State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI)Erika Jensen-Jarolim, Martin F Bachmann, Sergio Bonini, et al.
Journal for Immunotherapy of Cancer|May 25, 2019
Correction to: Vaccination with nanoparticles combined with micro-adjuvants protects against cancerMona O Mohsen, Matthew D Heath, Gustavo Cabral-Miranda, et al.
Journal for Immunotherapy of Cancer|April 28, 2019
Vaccination with nanoparticles combined with micro-adjuvants protects against cancerMona O Mohsen, Matthew D Heath, Gustavo Cabral-Miranda, et al.
Plos One|March 29, 2023
AA-amyloidosis in cats (Felis catus) housed in sheltersFilippo Ferri, Silvia Ferro, Federico Porporato, et al.
Plos One|November 9, 2013
Enhanced neutralizing antibody titers and Th1 polarization from a novel Escherichia coli derived pandemic influenza vaccineDavid A G Skibinski, Brendon J Hanson, Yufang Lin, et al.
Allergy|September 30, 2020
Accuracy of serological testing for SARS-CoV-2 antibodies: First results of a large mixed-method evaluation studyDaniel Brigger, Michael P Horn, Luke F Pennington, et al.
Allergy|September 8, 2021
A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2Mona O Mohsen, Ina Balke, Simon Zinkhan, et al.
Pageof 25

Showing results (241-250 of 250) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 250 results.
Allergy|March 8, 2023
The next generation virus-like particle platform for the treatment of peanut allergyJan M Sobczak, Pascal S Krenger, Federico Storni, et al.
Annals of Medicine|February 8, 2022
Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccinesQueenie Fernandes, Varghese Philipose Inchakalody, Maysaloun Merhi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2010
Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patientsDaniel E Speiser, Katrin Schwarz, Petra Baumgaertner, et al.
Allergy|November 28, 2019
State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI)Erika Jensen-Jarolim, Martin F Bachmann, Sergio Bonini, et al.
Journal for Immunotherapy of Cancer|May 25, 2019
Correction to: Vaccination with nanoparticles combined with micro-adjuvants protects against cancerMona O Mohsen, Matthew D Heath, Gustavo Cabral-Miranda, et al.
Journal for Immunotherapy of Cancer|April 28, 2019
Vaccination with nanoparticles combined with micro-adjuvants protects against cancerMona O Mohsen, Matthew D Heath, Gustavo Cabral-Miranda, et al.
Plos One|March 29, 2023
AA-amyloidosis in cats (Felis catus) housed in sheltersFilippo Ferri, Silvia Ferro, Federico Porporato, et al.
Plos One|November 9, 2013
Enhanced neutralizing antibody titers and Th1 polarization from a novel Escherichia coli derived pandemic influenza vaccineDavid A G Skibinski, Brendon J Hanson, Yufang Lin, et al.
Allergy|September 30, 2020
Accuracy of serological testing for SARS-CoV-2 antibodies: First results of a large mixed-method evaluation studyDaniel Brigger, Michael P Horn, Luke F Pennington, et al.
Allergy|September 8, 2021
A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2Mona O Mohsen, Ina Balke, Simon Zinkhan, et al.
Pageof 25